Emmaus Life Sciences (EMMA) Current Assets (2010 - 2026)
Emmaus Life Sciences' Current Assets was $6 million in Q2 2026, up 19.7% from $5.02 million a year earlier and up 0.1% from the prior quarter.
Emmaus Life Sciences (EMMA) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Emmaus Life Sciences came in at $7.75 million, up 14.5% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- In earlier years, Current Assets was $6.77 million in FY2024 (-41.2%), $11.51 million in FY2023 (+83.0%), $6.29 million in FY2022 (-30.8%) and $9.09 million in FY2021 (-19.2%).
- Quarterly Current Assets has moved between $4.79 million (Q3 2025) and $12.47 million (Q3 2021) over five years.
- Compared with a year earlier, Current Assets has increased for three straight quarters, with an average decline of 15.2% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2023 (growth of 83.0%); the worst was Q3 2021 (a decline of 69.5%).
- Per Business Quant data, EMMA's Current Assets in the three quarters before Q2 2026 was $6 million (Q1 2026), $7.75 million (Q4 2025) and $4.79 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 6.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 7.75 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 9.01 Mn |
| Mar 31, 2024 | 7.84 Mn |
| Dec 31, 2023 | 11.51 Mn |
| Sep 30, 2023 | 9.26 Mn |
| Jun 30, 2023 | 9.85 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 6.29 Mn |
| Sep 30, 2022 | 6.38 Mn |
| Jun 30, 2022 | 6.59 Mn |
| Mar 31, 2022 | 6.45 Mn |
| Dec 31, 2021 | 9.09 Mn |
| Sep 30, 2021 | 12.47 Mn |
Emmaus Life Sciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EMMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();